Cost-effectiveness results for the societal perspective across all participants at 12 months. -н Yong Yi Lee (12188837)

Нөхцлүүд:

Descriptive characteristics of participants at baseline by trial arm. -н Victoria Simms (25753)

Optimization results for two exemplary subjects in the same experimental condition (slow, 2 kg) but at different postures. -н Nils Grimmelsmann (13919183)

Нөхцлүүд:

Erratum: Simultaneous Occurrence of Biphenotypic T Cell/Myeloid Lesions Involving t(12;13)(p13;q14) in a Pediatric Patient -н Carneiro Borba C. (4272568)

Cost-effectiveness results for the health sector perspective across all participants at 12 months. -н Yong Yi Lee (12188837)

Нөхцлүүд:

ARM results at each time period. -н Silja Litvin (9333813)

“…<p>ARM results at each time period.</p>…”

Results of the multi-armed bandit experiments. -н Rachit Dubey (13199712)

Data from the studies involved with the research on "Understanding the Barriers to AI Adoption Within Primary Care: A Novel Model for Acceptance and Resistance." -н Teresa Sides (21489026)

“…A new moderator of stakeholder level is also included to ensure that all stakeholders are involved with any project using this framework from the outset and continually throughout the development and beyond.…”

Table_1_Cell Adhesion Molecules Involved in Neurodevelopmental Pathways Implicated in 3p-Deletion Syndrome and Autism Spectrum Disorder.XLSX -н Josan Gandawijaya (9979007)

“…Increasing evidence points toward the p-arm of chromosome 3 (chromosome 3p) as an ASD risk locus. …”

Illustration of the change of depth coordinates of the second data set of upper arm flexion in light clothing. -н Vytautas Abromavičius (22008573)

Illustration of the variation of the depth coordinates in the first test of the upper arm flexion of the first data set. -н Vytautas Abromavičius (22008573)

GLMM model comparisons of treatment and control arms: impact of metofluthrin emanators vs number of <i>Ae aegypti</i> per house. -н Azael Che-Mendoza (4102426)

Comparison of societal costs by trial arm, across all participants and stratified by prognostic group (multiple imputed data). -н Yong Yi Lee (12188837)

Нөхцлүүд:

Predicted Incidence Risk Ratio (IRR) for attempted landings. Negative-binomial GLMM results comparing the mosquito landings, between the treatment arm (CD and MD) and the control.... -н Azael Che-Mendoza (4102426)

“…Negative-binomial GLMM results comparing the mosquito landings, between the treatment arm (CD and MD) and the control. …”

DataSheet1_Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening.DOCX -н Caroline Lefeuvre (11672023)

“…</p><p>Methods: The study is a randomised controlled trial with three arms: a control arm (conventional invitation letter) and two experimental arms (mailing of a urine or vaginal self-sampling kit). …”

DataSheet2_Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening.doc -н Caroline Lefeuvre (11672023)

“…</p><p>Methods: The study is a randomised controlled trial with three arms: a control arm (conventional invitation letter) and two experimental arms (mailing of a urine or vaginal self-sampling kit). …”

DataSheet2_Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening.doc -н Caroline Lefeuvre (11672023)

“…</p><p>Methods: The study is a randomised controlled trial with three arms: a control arm (conventional invitation letter) and two experimental arms (mailing of a urine or vaginal self-sampling kit). …”

DataSheet1_Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening.DOCX -н Caroline Lefeuvre (11672023)

“…</p><p>Methods: The study is a randomised controlled trial with three arms: a control arm (conventional invitation letter) and two experimental arms (mailing of a urine or vaginal self-sampling kit). …”

Comparison of health sector costs by trial arm, across all participants and stratified by prognostic group (multiple imputed data). -н Yong Yi Lee (12188837)

Нөхцлүүд:

Outcomes in the two intervention arms over 12 weeks. -н Debritu Nane (11619300)

Нөхцлүүд: